Paroxysmal Nocturnal Hemoglobinuria
What is Paroxysmal Nocturnal Hemoglobinuria?
Paroxysmal nocturnal hemoglobinuria is a rare blood disorder that destroys red blood cells too early. The condition happens when your immune system attacks your own blood cells. This process is called complement-mediated hemolysis.
Your red blood cells normally have protective proteins on their surface. In this condition, genetic changes cause some cells to lack these shields. Without protection, your immune system breaks them down faster than your body can replace them. This leads to chronic anemia, or low red blood cell counts.
The disease can affect people at any age but often appears in young adults. Despite the name suggesting nighttime symptoms, hemolysis happens throughout the day. Regular monitoring helps catch disease activity early and guides treatment decisions.
Symptoms
- Dark or brown urine, especially in the morning
- Severe fatigue and weakness from anemia
- Shortness of breath during activity
- Pale skin and rapid heart rate
- Abdominal pain and difficulty swallowing
- Headaches and dizziness
- Unusual blood clots in uncommon locations
- Erectile dysfunction in men
Some people have mild symptoms for years before diagnosis. Others experience sudden episodes of worsening anemia. Symptoms often fluctuate as disease activity changes over time.
Concerned about Paroxysmal Nocturnal Hemoglobinuria? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Paroxysmal nocturnal hemoglobinuria starts with a genetic mutation in bone marrow stem cells. This mutation affects the PIG-A gene, which helps make protective surface proteins. The mutation happens after birth, not from parents. When these altered stem cells multiply, they produce red blood cells without proper defenses against immune attack.
Risk factors include having aplastic anemia or other bone marrow disorders. Exposure to certain toxins or radiation may damage bone marrow and trigger the condition. However, most cases appear without any known trigger. The disease progresses differently in each person, making regular blood monitoring essential for tracking activity.
How it's diagnosed
Doctors diagnose paroxysmal nocturnal hemoglobinuria using specialized flow cytometry tests. These tests check if red blood cells have the protective proteins they need. Blood tests also measure hemoglobin levels to assess anemia severity. Low hemoglobin combined with signs of hemolysis suggests active disease.
Regular hemoglobin monitoring through Rite Aid testing helps track disease activity over time. Hemoglobin levels often fluctuate as red blood cell destruction varies. Additional lab work checks for blood clotting problems and kidney function. Early detection through routine blood testing leads to better treatment outcomes and prevents serious problems.
Treatment options
- Complement inhibitor medications like eculizumab or ravulizumab to stop red blood cell destruction
- Folic acid supplements to support red blood cell production
- Blood transfusions during severe anemia episodes
- Anticoagulants to prevent dangerous blood clots
- Iron supplementation when deficiency occurs from chronic hemolysis
- Vaccination against certain infections before starting complement inhibitors
- Bone marrow transplant in severe cases for potential cure
- Regular monitoring of blood counts to adjust treatment
Concerned about Paroxysmal Nocturnal Hemoglobinuria? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Dark or brown urine happens when destroyed red blood cells release hemoglobin into your bloodstream. Your kidneys filter this hemoglobin out, giving urine a dark color. This color is often most noticeable in the first morning urine after red blood cells break down overnight.
Most doctors recommend hemoglobin testing every 3 to 6 months for stable disease. You may need more frequent testing if starting new treatment or experiencing symptoms. Regular monitoring helps your care team adjust medications and catch problems early. Rite Aid testing makes it convenient to track hemoglobin levels twice yearly.
Some people experience periods of stable disease with mild symptoms. However, true remission without treatment is rare. Complement inhibitor medications can stop hemolysis and create a stable state that mimics remission. Bone marrow transplant is currently the only potential cure.
When red blood cells break apart, they release substances that activate clotting. These clots often form in unusual places like abdominal veins or brain vessels. Blood clots are one of the most dangerous problems with this condition. Anticoagulant medications help prevent clotting in high-risk patients.
No, this condition is not passed from parents to children. The genetic mutation happens after birth in your bone marrow stem cells. It is an acquired condition, not an inherited one. Family members do not have increased risk of developing the disease.
Hemoglobin below 7 grams per deciliter usually requires urgent treatment like transfusion. Levels between 7 and 10 indicate significant anemia that needs close monitoring. Normal ranges are 12 to 16 for women and 14 to 18 for men. Your doctor will consider symptoms along with numbers when planning treatment.
Eating iron-rich foods and taking folic acid supports red blood cell production. Staying hydrated helps kidney function and may reduce clotting risk. Avoiding infections through good hygiene and vaccinations is important, especially on complement inhibitors. However, medications remain the primary treatment for controlling hemolysis.
Most people need lifelong treatment with complement inhibitors to control hemolysis. Stopping medication typically causes symptoms to return within weeks. These drugs are given by infusion every 2 to 8 weeks depending on the specific medication. Regular hemoglobin monitoring ensures treatment is working properly.
Sudden severe headache, abdominal pain, or chest pain may signal a clot. Leg swelling, redness, or warmth suggests deep vein thrombosis. Vision changes or difficulty speaking can indicate brain clots. Any of these symptoms requires immediate medical attention because clots can be life-threatening.
Some people develop aplastic anemia or myelodysplastic syndrome alongside this condition. These disorders also affect bone marrow function and blood cell production. Regular blood monitoring helps detect changes in other blood cell types. Your care team will watch for signs of bone marrow failure beyond hemolysis.